Independence of HIF1a and androgen signaling pathways in prostate cancer | BMC Cancer | Full Text

Independence of HIF1a and androgen signaling pathways in prostate cancer | BMC Cancer | Full Text

Independence of HIF1a and androgen signaling pathways in prostate cancer

Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progres...

Authors:Maxine G. B. Tran, Becky A. S. Bibby, Lingjian Yang, Franklin Lo, Anne Y. Warren, Deepa Shukla, Michelle Osborne, James Hadfield, Thomas Carroll, Rory Stark, Helen Scott, Antonio Ramos-Montoya, Charlie Massie, Patrick Maxwell, Catharine M. L. West, Ian G. Mills…

Citation:BMC Cancer 2020 20:469

Content type:Research article

Published on: 25 May 2020

• ViewFull Text
 
• ViewPDF